News
2d
Zacks Investment Research on MSNInspireMD Launches CGuard Prime Carotid Stent System in the U.S.InspireMD, Inc. NSPR recently announced the official commercial launch of the CGuard Prime Carotid Stent System in the United ...
Abstract: Arterial stiffness is recognized as an independent risk factor for cardiovascular events and has potential in vascular screening. We have developed `ARTSENS ® ', an image free system for ...
InspireMD, Inc. announced the commercial launch of the CGuard Prime carotid stent system in the United States. On June 24, the comp ...
InspireMD announced today that it launched its CGuard Prime carotid stent after receiving FDA premarket approval (PMA).
4d
InvestorsHub on MSNInspireMD Shares Rise on U.S. Rollout of CGuard Prime Carotid StentInspireMD Inc. (NASDAQ:NSPR) saw its shares rise 4% in premarket trading after the company officially launched its CGuard ...
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced the official commercial launch of the CGuard Prime carotid stent system ...
In this randomized trial, the use of cerebral embolic protection (CEP) did not decrease the 72-hour incidence of stroke in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results